The role of p53, Bcl-2 and Ki-67 in premalignant cervical lesions and cervical cancer

European Journal of Gynaecological Oncology

Volumn 28, Issue 4, 2007, Pages 290-293

  Turkcuoglu I ^a,c   Tezcan, S ^a   Kaygusuz, G ^b   Somer Atabekoglu C ^a   Ortac F ^a   Gungor M ^a   Kankaya, D ^b   Sertcelik A ^b  

^a Department of Obstetrics and Gynecology ^*

^b ANKARA UNIVERSITY   (Turkey)

^c Ortopedi Travmatoloji Anabilim Daly   (Turkey)

Author keywords

Bcl 2; Cervical cancer; Cervical intraepithelial neoplasia; Ki 67; p53

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ARTICLE; CANCER GRADING; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EROSION;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53; UTERINE CERVICAL NEOPLASMS;

EID: 34547813679     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Van Leeuwen A.M., Pieters W.J., Hollema H., Burger M.P.: "Atypical mitotic figures and the mitotic index in cervical intraepithelial neoplasia". Virchows Arch., 1995, 427, 139.
2. Schluter C., Duchrow M., Wohlenberg C., Becker M.H., Key G., Flad H.-D. et al.: "The cell proliferation-associated antigen of anti-body Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins". J. Cell Biol., 1993, 123, 513.
3. Kruse A.J., Baak J.P., de Bruin P.C., Jiwa M., Snijders W.P., Boodt P.J. et al.: "Ki-67 immunoquantitation in cervical intraepithelial neoplasia (CIN): a sensitive marker for grading". J. Pathol., 2001, 193, 48.
4. Bar J.K., Harlozinska A., Sedlaczek P., Kasiak J., Markowska J.: "Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias". Anticancer Res., 2001, 21, 1001.
5. Cheah P.L., Looi L.M.: "p53 immunohistochemical expression: messages in cervical carcinogenesis". Pathology, 2002, 34, 326.
6. Giarnieri E., Mancini R., Pisani T., Alderisio M., Vecchione A.: "Msh2, Mln1, Fhit, p53, Bcl-2, and Bax expression in invasive and in situ squamous cell carcinoma of the uterine cervix". Clin. Cancer Res., 2000, 6, 3600.
7. Dimitrakakis C., Kymionis G., Diakomanolis E., Papaspyrou I., Rodolakis A., Arzimanoglou I. et al.: "The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions". Gynecol. Oncol., 2000, 77, 129.
8. Delias A., Schultheiss E., Holzgreve W., Oberholzer M., Torhorst J., Gudat F.: "Investigation of the Bcl-2 and C-myc expression in relationship to the Ki-67 labelling index in cervical intraepithelial neoplasia". Int. J. Gynecol. Pathol., 1997, 16, 212.
9. Hollstein M., Sidransky D., Vogelstein B., Harris C.C.: "p53 mutations in human cancers". Science, 1991, 253, 49.
10. Vogelstein B.: "Cancer. A deadly inheritance". Nature, 1990, 348, 681.
11. Hunt C.R., Hale R.J., Buckley C.H., Hunt J.: "p53 expression in carcinoma of the cervix" J. Clin. Pathol., 1996, 49, 971.
12. Ngan H.Y., Liu S.S., Yu H., Liu K.L., Cheung A.N.: "Proto-oncogenes and p53 protein expression in normal cervical stratified squamous epithelium and cervical intra epithelial neoplasia". Eur. J. Cancer, 1999, 35, 1546.
13. Tjalma W.A., Weyler J.J., Bogers J.J., Pollefliet C., Baay M., Goovaerts G.C. et al.: "The importance of biological factors (Bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer". Eur. J. Obstet. Gynecol. Reprod. Biol., 2001, 97, 223.
14. Chen H.Y., Hsu C.T., Lin W.C., Tsai H.D., Chang W.C.: "Prognostic value of p53 expression in Stage IB1 cervical carcinoma". Gynecol. Obstet. Invest., 2000, 49, 266.
15. Finlay C.A., Hinds P.W., Tan T.H., Eliyahu D., Oren M., Levine AJ.: "Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life". Mol. Cell. Biol., 1988, 8, 531.
16. Kastan M.B., Onyekwere O., Sidransky D., Vogelstein B., Craig R.W.: "Participation of p53 protein in the cellular response to DNA damage". Cancer Res., 1991, 51, 6304.
17. Prives C., Hall P.A.: "The p53 pathway". J. Pathol., 1999, 187, 112.
18. Reed J.C.: "Bcl-2 and the regulation of programmed cell death". J. Cell. Biol., 1994, 124, 1.
19. Cooper K., Haffajee Z., Taylor L.: "bcl-2 immunoreactivity, human papillomavirus DNA, and cervical intraepithelial neoplasia". Mod. Pathol., 1999, 12, 612.
20. Kokawa K., Shikone T, Otani T., Nakano R.: "Apoptosis and the expression of Bax and Bcl-2 in squamous cell carcinoma and adenocarcinoma of the uterine cervix". Cancer, 1999, 85, 1799.
21. Cheung T.H., Chung T.K., Lo K.W., Yu M.Y., Krajewski S., Reed J.C. et al.: "Apotosis-related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix". Gynecol. Oncol., 2002, 86, 14.
22. Chung T.K.H., Cheung T.H., Lo W.K., Yim S.F., Yu M.Y., Krajewski S. et al.: "Expression of apoptotic regulators and their significance in cervical cancer" (letters). Cancer, 2002, 180, 63.
23. ter Harmsel B., Kuijpers J., Smedts F., Jeunink M., Trimbos B., Ramaekers F.: "Progressing imbalance between proliferation and apoptosis with increasing severity of cervical intraepithelial neoplasia". Int. J. Gynecol. Pathol., 1997, 16, 205.